Literature DB >> 21550667

CHRNA7 haplotypes are associated with impaired attention in euthymic bipolar disorder.

I Ancín1, J A Cabranes, J L Santos, E Sánchez-Morla, B Vázquez-Álvarez, L Rodríguez-Moya, A Pousada-Casal, C Fernández, A Aparicio, A Barabash.   

Abstract

BACKGROUND: Bipolar disorder (BD) patients show a deficit in sustained attention during euthymic periods. This deficit may be relevant for genetic studies in these patients. The α7 cholinergic receptor plays an important role in attentional deficit in humans and animal models. Moreover, there is evidence suggesting the role of the alpha 7 nicotinic cholinergic receptor subunit gene (CHRNA7) in BD susceptibility. The aim of the present study was to investigate the impact of CHRNA7 in sustained attention performance.
METHODS: We studied the association of a promoter variant (-86C/T) and three intronic polymorphisms, rs883473, rs6494223 and rs904952, in the non-duplicated region of CHRNA7 with sustained attention in 143 euthymic BD patients (based on DSM-IV criteria) and 101 healthy subjects. Sustained attention was assessed by the degraded stimulus (DS-CPT) version of Continuous Performance Test. Age, gender, years of education and IQ (WAIS vocabulary subtest) were controlled in the analyses as potential confounders.
RESULTS: Several candidate polymorphisms showed significant associations with different measures of the neuropsychological task for bipolar group. The CTCT haplotype was associated with an improvement in the attentional task performance in the BD group (p ≤ 0.025). On the other hand, different low frequency haplotypes showed influence in bipolar attentional performance (p ≤ 0.026). LIMITATIONS: A replication study using larger samples may be required for conclusive results.
CONCLUSIONS: Our results point toward a slight association of CHRNA7 genotypes and haplotypes with sustained attention performance in euthymic patients with BD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550667     DOI: 10.1016/j.jad.2011.04.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.

Authors:  Hong Lin; Fu-Chun Hsu; Bailey H Baumann; Douglas A Coulter; Stewart A Anderson; David R Lynch
Journal:  Mol Cell Neurosci       Date:  2014-06-28       Impact factor: 4.314

Review 2.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

Review 3.  Long-lasting changes in neural networks to compensate for altered nicotinic input.

Authors:  Danielle John; Darwin K Berg
Journal:  Biochem Pharmacol       Date:  2015-07-20       Impact factor: 5.858

4.  Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.

Authors:  Hong Lin; Fu-Chun Hsu; Bailey H Baumann; Douglas A Coulter; David R Lynch
Journal:  Neurobiol Dis       Date:  2013-12-08       Impact factor: 5.996

5.  Chrna7 deficient mice manifest no consistent neuropsychiatric and behavioral phenotypes.

Authors:  Jiani Yin; Wu Chen; Hongxing Yang; Mingshan Xue; Christian P Schaaf
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

6.  Is Chromosome 15q13.3 Duplication Involving CHRNA7 Associated With Oral Clefts?

Authors:  Yingjun Xie
Journal:  Child Neurol Open       Date:  2015-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.